Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures
Open Access
- 1 May 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 101 (2) , 352-363
- https://doi.org/10.1046/j.1365-2141.1998.00693.x
Abstract
We examined the effects of different cytokine combinations and culture conditions on the expansion and modulation of cell surface antigens of CD34+ derived dendritic cells (DCs), the most efficient antigen‐presenting cells capable of stimulating resting T cells in the primary immune response. Cells with a dendritic morphology and expressing HLA‐DR, CD1a, S100 and CD83 were maximally expanded under serum‐free conditions with the addition of SCF, GM‐CSF, TNF‐α, TGF‐β and Flt‐3 ligand (fold increase of CD1a+ cells = 102 ± 32 after 2 weeks of culture). CD34+ cells were also grown under continuous flow conditions in an artificial capillary system; after 14 d of culture, the expansion in the total cell number was lower than that of the static cultures (3.3 ± 2 v 18.9 ± 4) but the percentage of CD1a+/CD83+/CD80+ cells was considerably higher, whereas the CD14+ cells were significantly reduced (8.9 ± 2 v 26 ± 13). In continuous perfusion cultures, low levels of DC precursors and of LTC‐IC were still present up to day 14. The DCs generated under flow conditions stimulated the mixed leucocyte reaction (MLR) more than the cells grown in static cultures. By electron microscopy, cells grown in the continuous flow system showed an increased number of large cells with numerous dendritic processes and abundant multilamellar complexes. The cells expanded under these conditions were sorted on the basis of their light‐scatter properties into two fractions: one containing a predominance of CD1a+/S100+/CD83+/CD80+/CD14−‘large cells’ with great internal complexity (mature DCs); the second including ‘small cells’ either CD33+/CD14+, CD33+/CD15+ or CD33+/CD13±/CD14−. The DCs generated and selected with this method are therefore particularly well suited for immunotherapeutic protocols.Keywords
This publication has 27 references indexed in Scilit:
- Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.The Journal of Experimental Medicine, 1996
- Dendritic Cells in Antitumor Immune ResponsesCellular Immunology, 1996
- Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1995
- Stem cell factor augments tumor necrosis factor‐granulocyte‐macrophage colony‐stimulating factor‐mediated dendritic cell hematopoiesisThe International Journal of Cell Cloning, 1995
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- High gradient magnetic cell separation with MACSCytometry, 1990
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984